Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Vaxart, Inc. | vxrt20210715_8k.htm |
Exhibit 16.1
July 19, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-7561
Ladies and Gentlemen:
We have read Vaxart, Inc.’s statements included under Item 4.01 of its Form 8‑K dated July 19, 2021, and are in agreement with the statements contained therein concerning our firm in response to Item 304(a) of Regulation S-K.
Very truly yours,
/s/ OUM & Co. LLP